Annual Revenue
$4.60 M
+$462.10 K+11.17%
30 June 2024
Summary:
InMed Pharmaceuticals annual revenue is currently $4.60 million, with the most recent change of +$462.10 thousand (+11.17%) on 30 June 2024. INM annual revenue is now at all-time high.INM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$1.26 M
-$18.50 K-1.44%
30 September 2024
Summary:
InMed Pharmaceuticals quarterly revenue is currently $1.26 million, with the most recent change of -$18.50 thousand (-1.44%) on 30 September 2024. Over the past year, it has increased by +$362.70 thousand (+40.22%). INM quarterly revenue is now -45.28% below its all-time high of $2.31 million, reached on 30 June 2023.INM Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$4.96 M
+$362.70 K+7.89%
30 September 2024
Summary:
InMed Pharmaceuticals TTM revenue is currently $4.96 million, with the most recent change of +$362.70 thousand (+7.89%) on 30 September 2024. Over the past year, it has increased by +$243.80 thousand (+5.17%). INM TTM revenue is now -11.83% below its all-time high of $5.63 million, reached on 31 March 2024.INM TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INM Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.2% | +40.2% | +5.2% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
INM Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +322.0% | -45.3% | +377.0% | -11.8% | +1771.2% |
| 5 y | 5 years | at high | +322.0% | -45.3% | +377.0% | -11.8% | +1771.2% |
| alltime | all time | at high | >+9999.0% | -45.3% | +441.4% | -11.8% | >+9999.0% |
InMed Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.26 M(-1.4%) | $4.96 M(+7.9%) |
| June 2024 | $4.60 M(+11.2%) | $1.28 M(+9.4%) | $4.60 M(-18.3%) |
| Mar 2024 | - | $1.17 M(-5.5%) | $5.63 M(+2.5%) |
| Dec 2023 | - | $1.24 M(+37.5%) | $5.49 M(+16.3%) |
| Sept 2023 | - | $901.90 K(-61.0%) | $4.72 M(+14.1%) |
| June 2023 | $4.14 M(+279.6%) | $2.31 M(+123.5%) | $4.14 M(+76.8%) |
| Mar 2023 | - | $1.03 M(+120.1%) | $2.34 M(+44.8%) |
| Dec 2022 | - | $469.80 K(+46.4%) | $1.61 M(+14.5%) |
| Sept 2022 | - | $320.80 K(-37.7%) | $1.41 M(+29.4%) |
| June 2022 | $1.09 M(+2644.1%) | $514.80 K(+66.3%) | $1.09 M(+89.6%) |
| Mar 2022 | - | $309.60 K(+16.8%) | $574.70 K(+116.8%) |
| Dec 2021 | - | $265.10 K(>+9900.0%) | $265.10 K(+583.2%) |
| June 2011 | $39.70 K(-50.1%) | $100.00(-99.5%) | $38.80 K(-57.1%) |
| Mar 2011 | - | $20.80 K(+128.6%) | $90.40 K(+19.1%) |
| Dec 2010 | - | $9100.00(+3.4%) | $75.90 K(+8.9%) |
| Sept 2010 | - | $8800.00(-83.0%) | $69.70 K(-11.2%) |
| June 2010 | $79.50 K(-52.8%) | $51.70 K(+720.6%) | $78.50 K(+37.7%) |
| Mar 2010 | - | $6300.00(+117.2%) | $57.00 K(-4.4%) |
| Dec 2009 | - | $2900.00(-83.5%) | $59.60 K(-33.5%) |
| Sept 2009 | - | $17.60 K(-41.7%) | $89.60 K(-52.5%) |
| June 2009 | $168.40 K(-73.0%) | $30.20 K(+239.3%) | $188.50 K(-43.5%) |
| Mar 2009 | - | $8900.00(-72.9%) | $333.90 K(-41.8%) |
| Dec 2008 | - | $32.90 K(-71.8%) | $573.50 K(-45.2%) |
| Sept 2008 | - | $116.50 K(-33.7%) | $1.05 M(+0.8%) |
| June 2008 | $623.40 K | $175.60 K(-29.3%) | $1.04 M(+110.9%) |
| Mar 2008 | - | $248.50 K(-50.9%) | $492.50 K(-27.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | - | $505.90 K(+366.3%) | $680.80 K(+33.0%) |
| Sept 2007 | - | $108.50 K(-129.3%) | $511.90 K(-38.8%) |
| June 2007 | $825.80 K(-70.1%) | -$370.40 K(-184.8%) | $836.10 K(-53.1%) |
| Mar 2007 | - | $436.80 K(+29.6%) | $1.78 M(-7.8%) |
| Dec 2006 | - | $337.00 K(-22.1%) | $1.93 M(-21.5%) |
| Sept 2006 | - | $432.70 K(-24.9%) | $2.46 M(-10.9%) |
| June 2006 | $2.76 M(-34.8%) | $575.90 K(-2.0%) | $2.76 M(-19.5%) |
| Mar 2006 | - | $587.50 K(-32.1%) | $3.43 M(-17.2%) |
| Dec 2005 | - | $865.40 K(+17.9%) | $4.14 M(-7.6%) |
| Sept 2005 | - | $734.20 K(-40.9%) | $4.48 M(+6.3%) |
| June 2005 | $4.23 M(+102.3%) | $1.24 M(-4.5%) | $4.22 M(+23.4%) |
| Mar 2005 | - | $1.30 M(+8.1%) | $3.42 M(+29.5%) |
| Dec 2004 | - | $1.20 M(+156.1%) | $2.64 M(+37.7%) |
| Sept 2004 | - | $470.30 K(+6.3%) | $1.92 M(-10.2%) |
| July 2004 | $2.09 M(+1027.5%) | $442.30 K(-15.5%) | $2.14 M(+15.2%) |
| Apr 2004 | - | $523.60 K(+8.7%) | $1.85 M(+37.8%) |
| Jan 2004 | - | $481.60 K(-30.0%) | $1.35 M(+55.6%) |
| Oct 2003 | - | $687.80 K(+327.5%) | $864.70 K(+367.7%) |
| July 2003 | $185.60 K(+1244.9%) | $160.90 K(+944.8%) | $184.90 K(+401.1%) |
| Apr 2003 | - | $15.40 K(+2466.7%) | $36.90 K(+70.0%) |
| Jan 2003 | - | $600.00(-92.5%) | $21.70 K(+1.9%) |
| Oct 2002 | - | $8000.00(-38.0%) | $21.30 K(+54.3%) |
| July 2002 | $13.80 K(+475.0%) | $12.90 K(+6350.0%) | $13.80 K(+1433.3%) |
| Apr 2002 | - | $200.00(0.0%) | $900.00(+28.6%) |
| Jan 2002 | - | $200.00(-60.0%) | $700.00(+40.0%) |
| Oct 2001 | - | $500.00 | $500.00 |
| July 2001 | $2400.00 | - | - |
FAQ
- What is InMed Pharmaceuticals annual revenue?
- What is the all time high annual revenue for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual revenue year-on-year change?
- What is InMed Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly revenue year-on-year change?
- What is InMed Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals TTM revenue year-on-year change?
What is InMed Pharmaceuticals annual revenue?
The current annual revenue of INM is $4.60 M
What is the all time high annual revenue for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual revenue is $4.60 M
What is InMed Pharmaceuticals annual revenue year-on-year change?
Over the past year, INM annual revenue has changed by +$462.10 K (+11.17%)
What is InMed Pharmaceuticals quarterly revenue?
The current quarterly revenue of INM is $1.26 M
What is the all time high quarterly revenue for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly revenue is $2.31 M
What is InMed Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, INM quarterly revenue has changed by +$362.70 K (+40.22%)
What is InMed Pharmaceuticals TTM revenue?
The current TTM revenue of INM is $4.96 M
What is the all time high TTM revenue for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high TTM revenue is $5.63 M
What is InMed Pharmaceuticals TTM revenue year-on-year change?
Over the past year, INM TTM revenue has changed by +$243.80 K (+5.17%)